If you or a loved one has been hospitalized for ketoacidosis after taking Invokana and other similar type 2 diabetes medications, you may be entitled to compensation for your injuries.

After a safety warning was issued by the U.S. Food and Drug Administration (FDA) regarding these medications, the dangerous drug lawyers at Eicholz Law Firm have begun accepting cases on behalf of those who have suffered adverse reactions from treatment with these drugs.

 

Call today at (866) 947-7449 or complete a Free Case Evaluation form to see if you have a case.

SGLT2 Inhibitors Can Cause Serious Health Conditions

The U.S. Food and Drug Administration has released a drug safety warning against a newer class of type 2 diabetes medications produced by AstraZenica, Johnson & Johnson and Eli Lilly in partnership with Boehringer Inlgleheim for their potentially life-threatening side effects.

These drugs are classified as sodium-glucose cotransporter-2 (SGLT2) inhibitors and may be linked to a serious condition known has ketoacidosis, which can cause the body to produce high levels of blood acids known as ketones. It can often require hospitalization and can lead to diabetic coma and even death.

Signs of ketoacidosis include:

  • Difficulty breathing
  • Nausea
  • Vomiting
  • Abdominal pain
  • Confusion
  • Unusual fatigue

Patients being treated with this class of medication are advised to monitor their health and watch for these symptoms. At the first sign of the above indicators, seek immediate medical attention.

Problems Tied to Invokana, Invokamet, Farxiga

SGLT2 inhibitors have been approved by the FDA to help lower blood sugar in adults with type 2 diabetes when used in association with diet and exercise.

Unfortunately, many of these drugs have produced serious adverse side effects and caution is advised for those taking the following medications:

  • Farxiga (dapagliflozin)
  • Glyxambi (empagliflozin and linagliptin)
  • Invokamet (canagliflozin and metformin)
  • Invokana (canagliflozin)
  • Jardiance (empagliflozin)
  • Xigduo XR (dapagliflozin and metformin extended-release)

SGLT2 Inhibitors Can Cause Ketoacidosis

The FDA’s Adverse Event Reporting System database has identified 20 cases of diabetic ketoacidosis, ketoacidosis and ketosis in patients receiving treatment with SGLT2 inhibitors between May 2013 and June 2014.

In all instances of the condition, the patients required hospitalization and visits to the emergency room.

Additional complaints have also been filed since June 2014 for patients suffering from ketoacidosis after treatment by SGLT2 inhibitors.

The FDA has not yet issued a recall on the products, but it is investigating the potential need for changes in the prescription information for this class of drugs.

Legal Help for Victims of Bad Diabetes Drugs

If you have suffered adverse side effects after taking any of these type 2 diabetes medications, you may be entitled to compensation through a class action lawsuit.

The Eichholz Law Firm is dedicated to fighting for the rights of those who have fallen victim to large pharmaceutical companies. We have decades of experience in dangerous drug litigation and can help you get the maximum level of compensation available for your claim.